CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop innovative therapeutic strategies for neurodegenerative disorders by utilizing cell-permeable peptides and small molecules. It focuses on creating new drug candidates through collaboration between academic and commercial entities.
Peptides and small molecules able to modulate protein-protein interaction as well as intracellular pathways leading to neurodegeneration and cell death hold a great potential as innovative therapeutic strategies with which to probe and manipulate biological pathways.
The need to deliver these biologically active agents into cells has encouraged to develop various transducing vectors.
In this view, cell permeable peptides conjugates represent a novel, versatile and extremely powerful way of bloc…
UNIVERSITA DEGLI STUDI DI MILANO
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Switzerland, LAUSANNE
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
CF CONSULTING FINANZIAMENTI UNIONE EUROPEA SRL
Italy, Milano
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
France, GIF SUR YVETTE CEDEX
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
